Atlas Trials

KRAS Gene Mutation

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch KRAS Gene Mutation

RecordFirmDate
Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer (NCT04965818)Taiho Oncology, Inc.2021-09-20
Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas (NCT03808558)David E Gerber2019-09-11
Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer (NCT03777124)Jiangsu HengRui Medicine Co., Ltd.2019-07-11
A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors (NCT03965845)Calithera Biosciences, Inc2019-06-25
Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation (NCT03829410)Cardiff Oncology2019-06-24
Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer (NCT03704688)Memorial Sloan Kettering Cancer Center2018-10-09
Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer (NCT03520842)Stanford University2018-08-14
OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer - (NCT03750175)Karen-Lise Garm Spindler2018-06-01
Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer (NCT03087071)M.D. Anderson Cancer Center2017-12-29
Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation (NCT03065387)M.D. Anderson Cancer Center2017-10-31
Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC. (NCT02964689)Swiss Cancer Institute2017-04-12
Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer (NCT02642042)National Cancer Institute (NCI)2016-07-18
Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer Patients (NCT03171636)Hospital Erasto Gaertner2014-04-01
French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings (NCT01700582)Intergroupe Francophone de Cancerologie Thoracique2012-04-01
I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations (NCT02818725)UNICANCER2010-06-01
Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer (NCT04446793)Cardiff Oncology

Track KRAS Gene Mutation automatically

Every clearance here is in the API, with alerts when new ones post.